Her current work focuses on (1) conducting placebo-controlled studies testing the efficacy of potential treatment medications for Cannabis Use Disorder, and (2) testing the potential therapeutic effects of cannabis and its constituents for a range of indications, including appetite-enhancement and pain. Dr. Haney’s research has been continuously supported by the National Institute of Health since 1999. She has authored more than 145 articles in peer-reviewed journals, 12 book chapters, is an Associate Editor for Cannabis and Cannabinoid Research, is an Advisory Editor for Psychopharmacology, and recently co-edited Neuropsychopharmacology Reviews 2018, Cannabis and Cannabinoids: From Synapse to Society. Dr. Haney is a longstanding participant in NIH review groups, is an elected Fellow at the American College of Neuropsychopharmacology, and is the recent past President of the College on Problems of Drug Dependence (2019).